2018 |
R21 |
CA214239 |
RFA-CA-17-010 |
VAN DEVENTER, JAMES ALLEN |
TUFTS UNIVERSITY MEDFORD |
Discovering hybrid inhibitors for tumor microenvironment disruption |
NCE |
2018 |
R21 |
CA229037 |
RFA-CA-17-012 |
GULLEY, MARGARET L |
UNIV OF NORTH CAROLINA CHAPEL HILL |
EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing |
Active |
2018 |
R21 |
CA223836 |
RFA-CA-17-010 |
FIELDS, RYAN C |
WASHINGTON UNIVERSITY |
Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment |
NCE |
2018 |
R33 |
CA223947 |
RFA-CA-17-011 |
BROWN, BRIAN D |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
Pro-Codes: A novel vector and cell barcoding technology |
Active |
2018 |
R21 |
CA225507 |
RFA-CA-17-012 |
PAULOVICH, AMANDA G |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome |
NCE |
2018 |
R21 |
CA229057 |
RFA-CA-17-010 |
FU, XIAO-AN |
UNIVERSITY OF LOUISVILLE |
A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath |
Active |
2018 |
R33 |
CA223581 |
RFA-CA-17-011 |
CHENG, JI-XIN |
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) |
Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level |
Active |
2018 |
R21 |
CA229027 |
RFA-CA-17-012 |
SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN |
WAKE FOREST UNIVERSITY HEALTH SCIENCES |
Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids |
Complete |
2018 |
R21 |
CA223915 |
RFA-CA-17-010 |
KARGINOV, ANDREI V |
UNIVERSITY OF ILLINOIS AT CHICAGO |
Optogenetic tools for the dissection of oncogenic signaling mediated by kinases |
NCE |
2018 |
R33 |
CA223904 |
RFA-CA-17-011 |
CIMA, MICHAEL J |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors |
NCE |
2018 |
R33 |
CA217702 |
RFA-CA-17-013 |
BORGES, CHAD R |
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity |
Active |
2018 |
R21 |
CA214285 |
RFA-CA-17-010 |
MAILLOUX, ADAM WILLIAM |
H. LEE MOFFITT CANCER CTR & RES INST |
Autohistomagnetic Isolation of Tumor-reactive T-cells |
Complete |
2018 |
R33 |
CA225539 |
RFA-CA-17-011 |
JIANG, NING |
UNIVERSITY OF TEXAS, AUSTIN |
An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer |
Active |
2018 |
R33 |
CA214310 |
RFA-CA-17-013 |
INCE, TAN A. |
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE |
Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers |
Complete |
2018 |
R21 |
CA225474 |
RFA-CA-17-010 |
MEHTA, ANAND S |
MEDICAL UNIVERSITY OF SOUTH CAROLINA |
Glyco-typer: an antibody capture glycan imaging methodology |
NCE |
2018 |
R33 |
CA223908 |
RFA-CA-17-011 |
KONRY, TANIA TALI |
NORTHEASTERN UNIVERSITY |
Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform |
NCE |
2018 |
R43 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues |
Active |
2017 |
R21 |
CA213234 |
RFA-CA-16-003 |
WELJIE, AALIM M |
UNIVERSITY OF PENNSYLVANIA |
Determining and enhancing metabolite fitness for metabolomics measurements |
Complete |
2017 |
R33 |
CA206939 |
RFA-CA-16-004 |
PATTENDEN, SAMANTHA GAIL |
UNIV OF NORTH CAROLINA CHAPEL HILL |
The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues |
NCE |
2017 |
R21 |
CA212500 |
RFA-CA-16-001 |
MOHS, AARON M. |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications |
NCE |
2017 |
R43 |
CA214386 |
PAR-13-327 |
PEYTAVI, REGIS |
BLUENOVO BIOSYSTEMS, INC. |
Detection of Methylation and Translocation Events by Novel Sequencing Technology |
Complete |
2017 |
R21 |
CA213247 |
RFA-CA-16-001 |
KRON, STEPHEN J. |
UNIVERSITY OF CHICAGO |
Tag-ChIP-MS for analysis of chromatin-level regulation of DNA repair |
Complete |
2017 |
R33 |
CA212697 |
RFA-CA-16-002 |
KLEIN, ALLON MOSHE |
HARVARD MEDICAL SCHOOL |
Droplet microfluidic technology for single cell cancer genomics |
Complete |
2017 |
R21 |
CA212718 |
RFA-CA-16-001 |
VAN DAM, ROBERT MICHAEL |
UNIVERSITY OF CALIFORNIA LOS ANGELES |
High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer |
Complete |
2017 |
R44 |
CA188154 |
PAR-13-327 |
PREMSRIRUT, PREM KHOVABUTR |
MIRIMUS, INC. |
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research |
Complete |
2017 |
R21 |
CA214233 |
RFA-CA-16-001 |
SOELLNER, MATTHEW B |
UNIVERSITY OF MICHIGAN AT ANN ARBOR |
Exquisitely selective turn-on probes of kinase activation and localization |
NCE |
2017 |
R33 |
CA212806 |
RFA-CA-16-004 |
ZILBERBERG, JENNY |
HACKENSACK UNIVERSITY MEDICAL CENTER |
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells |
NCE |
2017 |
R21 |
CA212726 |
RFA-CA-16-001 |
NAEGLE, KRISTEN M |
WASHINGTON UNIVERSITY |
A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS |
NCE |
2017 |
R21 |
CA214299 |
RFA-CA-16-001 |
SLATER, JOHN HUNDLEY |
UNIVERSITY OF DELAWARE |
A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases |
NCE |
2017 |
R33 |
CA212968 |
RFA-CA-16-002 |
SINGH, ANKUR |
CORNELL UNIVERSITY |
LETSSGo: Lymphoma-on-chip Engineered Technology for Single-Organoid Sequencing and Genomics |
Complete |
2017 |
R21 |
CA212731 |
RFA-CA-16-001 |
DAVIS, RONALD WAYNE |
STANFORD UNIVERSITY |
Nanoneedle microrobots for single cancer cell manipulation and genome editing |
Complete |
2017 |
R21 |
CA217695 |
RFA-CA-16-001 |
LEVINSON, NICHOLAS MARK |
UNIVERSITY OF MINNESOTA |
A novel time-resolved fluorescence-based high-throughput screening technology for discovering allosteric kinase inhibitors |
Complete |
2017 |
R33 |
CA212973 |
RFA-CA-16-002 |
YATES, JOHN R |
SCRIPPS RESEARCH INSTITUTE |
Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry |
Complete |
2017 |
R21 |
CA212827 |
RFA-CA-16-001 |
WONG, WESLEY PHILIP |
BOSTON CHILDREN'S HOSPITAL |
Single-molecule mechanical detection of protein and microRNA cancer biomarkers |
Complete |
2017 |
R21 |
CA217751 |
RFA-CA-16-003 |
NECHAEV, SERGEI |
UNIVERSITY OF NORTH DAKOTA |
Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments. |
NCE |
2017 |
R33 |
CA214176 |
RFA-CA-16-002 |
LU, CHANG |
VIRGINIA POLYTECHNIC INST AND ST UNIV |
Next-generation MOWChIP-seq for high-throughput epigenomic profiling using clinically relevant samples |
Complete |
2017 |
R21 |
CA212907 |
RFA-CA-16-001 |
KARGINOV, ANDREI V |
UNIVERSITY OF ILLINOIS AT CHICAGO |
Engineered regulation of tyrosine phosphatase activity in living cells |
NCE |
2017 |
R21 |
CA217754 |
RFA-CA-16-001 |
DICKINSON, BRYAN |
UNIVERSITY OF CHICAGO |
rePPI-i: A system for the rapid continuous evolution of protein-protein interaction inhibitors |
NCE |
2017 |
R33 |
CA214333 |
RFA-CA-16-002 |
ZENG, YONG |
UNIVERSITY OF KANSAS LAWRENCE |
Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer |
Complete |
2017 |
R21 |
CA212928 |
RFA-CA-16-001 |
BROCK, AMY |
UNIVERSITY OF TEXAS, AUSTIN |
High resolution cell lineage tracking and isolation |
NCE |
2017 |
R33 |
CA202881 |
RFA-CA-16-002 |
LEVENSON, RICHARD M. |
UNIVERSITY OF CALIFORNIA AT DAVIS |
Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy |
Complete |
2017 |
R33 |
CA217652 |
RFA-CA-16-002 |
MAKRIGIORGOS, G. MIKE |
DANA-FARBER CANCER INST |
Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes |
NCE |
2017 |
R21 |
CA212932 |
RFA-CA-16-001 |
WONG, IAN Y |
BROWN UNIVERSITY |
High Content Screening of Multicellular Invasion with 3D Traction Force Microscopy |
Complete |
2017 |
R33 |
CA204574 |
RFA-CA-16-002 |
KELLEY, SHANA O |
UNIVERSITY OF TORONTO |
Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis |
Complete |
2017 |
R21 |
CA204560 |
RFA-CA-16-001 |
WALTER, NILS G |
UNIVERSITY OF MICHIGAN AT ANN ARBOR |
Single-molecule counting of cancer biomarker miRNAs in human biofluids |
Complete |
2017 |
R33 |
CA217699 |
RFA-CA-16-002 |
IBRAHIM, YEHIA |
BATTELLE PACIFIC NORTHWEST LABORATORIES |
High Resolution High Throughput Proteomics Platform for Cancer Research |
NCE |
2017 |
R21 |
CA212958 |
RFA-CA-16-001 |
KESHARI, KAYVAN R. |
SLOAN-KETTERING INST CAN RESEARCH |
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells |
Complete |
2017 |
R33 |
CA204704 |
RFA-CA-16-002 |
WANG, YINGXIAO |
UNIVERSITY OF CALIFORNIA, SAN DIEGO |
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells |
Complete |
2017 |
R21 |
CA204708 |
RFA-CA-16-001 |
MALMSTADT, NOAH |
UNIVERSITY OF SOUTHERN CALIFORNIA |
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display |
Complete |
2017 |
R33 |
CA217700 |
RFA-CA-16-002 |
WALTER, MATTHEW J |
WASHINGTON UNIVERSITY |
TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES |
NCE |